MC
ZVRA icon

Menta Capital’s Zevra Therapeutics ZVRA Stock Holding History

Menta Capital’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,683
Closed -$109K – 777
2017
Q4 		$109K Sell
1,683
-56
-3% -$3.38K 0.02% 603
2017
Q3 		$103K Sell
1,739
-376
-18% -$20K 0.02% 726
2017
Q2 		$135K Sell
2,115
-438
-17% -$28.8K 0.02% 727
2017
Q1 		$200K Sell
2,553
-387
-13% -$23.5K 0.02% 754
2016
Q4 		$139K Hold
2,940
– – 0.01% 821
2016
Q3 		$211K Hold
2,940
– – 0.02% 728
2016
Q2 		$187K Buy
2,940
+2,227
+312% +$366K 0.03% 785
2016
Q1 		$165K Buy
713
+72
+11% +$17.4K 0.02% 835
2015
Q4 		$204K Buy
+641
New +$174K 0.03% 761

Other funds holding ZVRA

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return